L3VLUP
ProSign in

GMAB · JNJ in the 13F filings

Two to four stocks side by side among the 95 tracked managers: who lists them, how that has moved, who bought and sold in a quarter, and which managers hold more than one.

GMABJNJ
Quarter
Q2 2026Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024Q2 2024Q1 2024Q4 2023

Holders over time

Tracked managers listing each stock every quarter, at least, or their combined reported value. A gap is a quarter in which no tracked manager listed it. Click a quarter to compare there.
  • GMAB
  • JNJ
0204060202120222023202420252026
Holders and value by quarter
QuarterGMABJNJ
Q3 20207 holders, $364m30 holders, $26.2bn
Q4 20205 holders, $238m32 holders, $26.6bn
Q1 20213 holders, $121m31 holders, $25.3bn
Q2 20213 holders, $187m37 holders, $25.6bn
Q3 20213 holders, $166m40 holders, $24.1bn
Q4 20213 holders, $168m33 holders, $25.2bn
Q1 20224 holders, $168m35 holders, $28.2bn
Q2 20224 holders, $96m33 holders, $26.9bn
Q3 20227 holders, $412m36 holders, $25.4bn
Q4 20226 holders, $422m35 holders, $27.6bn
Q1 20233 holders, $333m42 holders, $24.5bn
Q2 20232 holders, $343m38 holders, $25.0bn
Q3 20233 holders, $385m37 holders, $18.9bn
Q4 20234 holders, $548m31 holders, $19.0bn
Q1 20246 holders, $540m32 holders, $19.7bn
Q2 20246 holders, $457m35 holders, $20.4bn
Q3 20246 holders, $447m28 holders, $22.3bn
Q4 20248 holders, $480m37 holders, $20.4bn
Q1 20258 holders, $495m32 holders, $20.5bn
Q2 202510 holders, $495m31 holders, $18.4bn
Q3 20257 holders, $643m32 holders, $23.7bn
Q4 20255 holders, $617m29 holders, $27.8bn
Q1 20266 holders, $623m34 holders, $35.6bn
Q2 20267 holders, $583m33 holders, $39.1bn
GMAB

Genmab A S

Holders
10
Reported value
$495m
Buyers
3
Sellers
7

Breadth -4 among 95 comparable managers.

Pharmaceuticals and biotechnologyHealthcare: biopharma and medtech · L3VLUPPharmaceutical preparations
JNJ

Johnson & Johnson

Holders
31
Reported value
$18.4bn
Buyers
15
Sellers
16

Breadth -1 among 95 comparable managers.

Pharmaceuticals and biotechnologyHealthcare: biopharma and medtech · L3VLUPPharmaceutical preparations

Who holds both, Q2 2025

Among the 34 tracked managers listing any of them. "Only" is about listed positions: a manager may hold the other below its listed range.

Only GMAB (3)

Baillie Gifford & Co, Hudson Bay Capital Management LP, Voloridge Investment Management LLC

Only JNJ (24)

Acadian Asset Management LLC, AQR Capital Management LLC, Brevan Howard Capital Management LP, Bridgewater Associates LP, Capital Research Global Investors, Caxton Associates LLP, D. E. Shaw & Co., Dodge & Cox, Eisler Capital Management Ltd, Fidelity (FMR LLC), GAMCO Investors Inc, Invesco Ltd, Janus Henderson Group Ltd, Man Group PLC, Markel Group Inc, MFS Investment Management, Millennium Management LLC, Neuberger Berman Group LLC, Point72 Asset Management LP, Quantbot Technologies LP, T. Rowe Price Associates Inc, Verition Fund Management LLC, Wellington Management Group LLP, Winton Group Ltd

How much of the picture this is

A 13F is a manager’s long US-listed equity book at a quarter end, filed up to 45 days later. Buyers and sellers count comparable managers (those that filed both quarters) by shares, so a rise in value with no rise in shares is the price. Large books are listed to their largest positions. These are 95 tracked managers, not the institutional market.

Back to the 13F Explorer →